• Focused on improving patient care

  • Quality matters

  • Understanding the fragility and value of life

  • Developing future solutions for unmet patient needs


News

01.03.2017
Octapharma Group publishes 2016 annual results reporting revenue of €1.6 billion and operating income of €383 million

Lachen, Switzerland, March 1st, 2017: The Octapharma Group can report a record-breaking result with ...

22.12.2016
Octapharma donates Nuwiq® to the WFH Humanitarian Aid Program to provide patients with haemophilia A in developing countries access to therapy

Lachen, Switzerland, December 22nd, 2016: Octapharma is proud to announce that the company has made ...

Since its establishment over 30 years ago, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map

“As a world-wide provider of human proteins as treatments in immunotherapy, haematology, and intensive care and emergency medicine, Octapharma is constantly investing in the renovation and modernisation of our plants.„

Wolfgang Marguerre
Chairman of the Board